Impact of symptoms and risk of ASMD on patients and caregivers

Objective and Methodology

A survey was conducted to quantify:

Object case: BWS was used to explore 15 ASMD symptoms/risks.

Results

Baseline characteristics

Median age

5 years for patients in the US
3 years for children of parents from the US and the UK

Symptoms

Abdominal enlargement
Abdominal pain
Fatigue
Shortness of breath

Cognitive pretesting interviews

Parents and patients reported difficulty in identifying ASMD-associated symptoms.
Parents were unaware of their child experiencing ASMD symptoms unless indicated by the child.

BWS results

Patients and parents

The largest differences in severity levels were observed for:

Fatigue
Joint pain
Abdominal pain

Conclusion

Patients and parents had similar preferences for ranking symptoms/risks.
A wide range of symptoms displayed heterogeneity in samples.

^*Severe fatigue: Fatigue so severe that the respondent might need help taking care of themselves and doing daily activities.

Abbreviations

ASMD: Acid sphingomyelinase deficiency; BWS: Best–worst scaling; NNPDF: National Niemann-Pick Disease Foundation; NPUK: Niemann-Pick United Kingdom; UK: United Kingdom; US: United States.

Reference

Mansfield C, Nalysnyk L, Joshi D, et al. Impact of potential symptoms and risks associated with acid sphingomyelinase deficiency on patients and caregivers: A best-worst scaling study. Patient Prefer Adherence. 2023;17:927–939.

Management of ASMD - Expert opinion: Professor Moeen Al Sayed

Professor Moeen gives a detailed explanation on how Olipudase Alfa acts in the body once administered.

Read article

Navigating the Pompe Disease Journey

Recognizing key signs and symptoms along the way

Read article

Differential diagnostics for ASMD in patients suspected to have GD

Read article

MAT-BH-2400114-V1-February 2024